Cannabis Retail Sales are Expected to Expand as CBD-Infused Beverage Appeal Grows

Tuesday, October 30, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

FinancialBuzz.com News Commentary

NEW YORK, October 30, 2018 /PRNewswire/ --

According to a research

report provided by Marijuana Business Daily, cannabis retail sales continued to grow year-over-year as new markets appeared and more states legalized medical and recreational cannabis products. Sales in 2018 are expected to increase by approximately
50% when compared to 2017. Additionally, sales value is on track to reach USD 8 Billion - USD 10 Billion by the end of this year. The report also indicated that by 2022, annual retail cannabis sales in the United States could surpass the USD 20 Billion mark, a 200% increase from 2017. As for the economic impact that the growing industry is set to have, the data predicts an estimated USD 28 Billion - USD 34 Billion of economic impact in 2018. American Premium Water Corporation (OTC: HIPH), Cronos Group Inc. (NASDAQ: CRON), Terra Tech Corp. (OTC: TRTC), Aleafia Health Inc. (OTC: ALEAF), Freedom Leaf Inc. (OTC: FRLF)

The increasing popularity of cannabidiol (CBD) oil products is one of the primary growth factors for the market. A major segment of the CBD market is represented by cannabis-infused beverages. This segment is expected to grow rapidly after mainstream beverage companies showed interests in the cannabis-infused drinks. According to Business Insider, analysts at Canaccord Genuity expect that the U.S. cannabis-infused beverages market could reach USD 600 Million in the next four years. Canaccord's Bobby Burleson and Jonathan DeCourcey wrote in a note: "While these trends represent a significant opportunity for US cannabis companies, they have not gone unnoticed by large mainstream beverage players looking to inject growth into their product portfolio."

American Premium Water Corporation (OTC: HIPH) yesterday announced breaking news that, "it has entered into an agreement with Canna Nano (http://www.cannanano.com/ ) regarding a prestigious collaboration to produce nano-infused cannabidiol (CBD) water. The Company will begin selling this product through all its distribution channels. In addition, the Company is in advanced discussions with Canna Nano regarding a long-term partnership, including potential acquisition structures of Canna Nano by the Company.

'I am excited to announce this collaboration with Canna Nano. Their brand aligns with American Premium's LALPINA brand. This collaboration we have created opens doors for both companies and sets the stage to open many more together down the road. Canna Nano is a great brand, and I am excited to be working with Ed and his team as we begin launching marketing and co-branding opportunities for this product,' commented American Premium CEO Ryan Fishoff.

'We are really stoked to be working with LALPINA and American Premium Water. This "prestigious" collaboration aligns Canna Nano with the great lifestyle brand LALPINA. The brand (LALPINA) encapsulates many of the core principles of Canna Nano, and I am very proud of the collaboration we have created here. There are so many possibilities that we can accomplish working with the two brands. I am really excited about the exposure that will be created and lead to additional distribution. I see this as the first step in a longer-term partnership between the companies,' stated Ed Serafin, founder of Canna Nano.

Canna Nano is based in Huntington Beach, California. Currently, the company manufactures, markets and distributes a variety of cannabis and CBD-infused products under its Canna Nano label as well as other brands, including CBD-infused creams, pipes, vaporizers and other related devices. Canna Nano currently has distribution online and in eight states: Arizona, California, Georgia, Louisiana, Kansas, Maryland, Nevada and New Jersey.    

'Canna Nano has a robust distribution network across the country, and it will complement the geographic focus markets American Premium is in the process of building out. This collaboration is just the first step in the Company's growth strategy, including the development of more CBD- and THC-infused beverages. This collaboration will not only generate revenue for the Company, but it will also streamline our fulfillment, optimizing for a high level of efficiency for our customers. Canna Nano will be an instrumental part of our strategy going forward from a distribution and acquisition perspective. In addition to the discussions I have previously mentioned, we have been in talks with them for many months about a long-term partnership, and I am optimistic a structure will be created that will benefit both companies for the long term. As things develop and progress, I look forward to providing updates to the Company's shareholders,' added Mr. Fishoff."

Cronos Group Inc. (NASDAQ: CRON) recently announced that it has entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion - Israel Institute of Technology, to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair. "We believe that the potential applications of cannabinoids to regulate skin health and treat skin disorders are vast, and we are excited to begin exploring these applications through our partnership with Technion," said Mike Gorenstein, Chief Executive Officer of Cronos Group. "Using rigorous data to develop efficacious topical and transdermal formulations will be key to creating differentiated products that provide quality treatments to our consumers and strengthen our brand portfolio."

Terra Tech Corp. (OTCQX: TRTC) is a vertically integrated cannabis-focused agriculture company. Recently, the Company announced it has completed its previously announced sale of 100% of the assets of its cannabis dispensary located at 1921 Western Avenue in Las Vegas, to Exhale Brands Nevada, for a total consideration of USD 6,250,000. The Company plans to use the proceeds from the sale to further develop its retail dispensary capabilities in new locations that have better proximity to major tourist attractions in Las Vegas. The Company already has a strong footprint in Nevada. It currently operates its Blüm, Desert Inn Road and Blüm, Decatur Boulevard dispensaries, both of which are located in Las Vegas, as well as its Blüm Reno dispensary, in Northwest Nevada. The Company also recently purchased a retail property in downtown Las Vegas, located at 121 North Fourth Street, which it plans to convert into a Blüm retail dispensary. As owners of medical and adult-use cannabis business licenses in Las Vegas associated with these dispensaries, Terra Tech has the ability to apply for additional licenses based on its grandfather status. The Company also has two pending applications for additional retail permits in Las Vegas.

Aleafia Health Inc. (OTCQX: ALEAF) is a vertically integrated, national cannabis company with major medical clinic, cannabis cultivation and R&D operations. Aleafia Health Inc. recently announced that it is formally launching a research, development and innovation division to be called Aleafia Labs. Aleafia Labs will leverage the Company's existing patient database and intellectual property to advance the development of proprietary cannabis products. R&D activities will focus on the development of cannabis products that may act as a replacement for addictive prescription opioids and sleeping aids. "Aleafia is uniquely positioned to develop intellectual property and commercial products following a data-driven approach," said President of Clinic Operations, Dr. Gary Goodyear. "While the relationship most cannabis companies have with their patients ends at the point of sale, our physicians closely monitor and track a patient's progress throughout the entire treatment cycle. This unique data will lead to the development of innovative cannabis products."

Freedom Leaf Inc. (OTCQB: FRLF) is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and education as well as cannabis media companies. Freedom Leaf Inc. recently announced that it has received a significant investment from cannabis private equity firm Merida Capital Partners to further expand its existing U.S. sales channels and accelerate its European hemp cultivation operations. Freedom Leaf and Merida have also agreed in principle to a strategic partnership by which Merida will provide certain operational resources and support for both Freedom Leaf's US hemp-based cannabidiol (CBD) sales efforts and their global cultivation operations. In connection with Merida's investment, Merida Senior Partner David Goldburg will be joining the Freedom Leaf Board of Directors. Clifford Perry, Chief Executive Officer of Freedom Leaf, commented on the investment and partnership, "Receiving an investment from a leading cannabis firm like Merida, which already has investments in key supply chain providers like KushCo, GrowGeneration and Emerald Scientific, should drive our US expansion and ensure we are building our CBD production business efficiently, while also giving us incredible support in our global expansion."

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz  

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For american premium water corporation. financial and corporate news dissemination, FinancialBuzz.com has been compensated four thousand dollars by meridian ventures. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .

Media Contact: info@financialbuzz.com +1-877-601-1879

Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store